Pneumonia News

The Healio Editors have compiled a list of the most-read news in pulmonology posted in August.

Bacterial superinfection was present at the time of intubation in 21% of patients with severe COVID-19 pneumonia, according to new research published in the American Journal of Respiratory and Critical Care Medicine.

In China, of the number of adults with pleural effusions is high, and causes appear to differ by age and smoking status, according to new findings published in JAMA Network Open.

In a new study, children with pneumonia diagnosed during infancy had an increased risk for asthma at age 4 years.

Computerized versions of the Pneumonia Severity Index accurately identified patients with community-acquired pneumonia at low risk for death, according to data published in the Annals of the American Thoracic Society.

The FDA recently approved Vaxneuvance, Merck’s 15-valent pneumococcal conjugate vaccine, for adults aged 18 years or older.

Canakinumab fails to significantly increase the likelihood of survival without accompanying invasive mechanical ventilation, compared with placebo, in patients with severe COVID-19, according to data published in JAMA.

Obesity does not appear to be associated with an increased incidence of ventilator-associated pneumonia among adults receiving invasive mechanical ventilation and vasopressor support, according to results published in Chest.

Three days of antibiotic therapy was noninferior to 8 days of therapy for patients with moderately severe community-acquired pneumonia, according to a study published in The Lancet.

Solar-powered oxygen delivery was a cost-effective intervention for treating hypoxemia in young children in low- and middle-income countries, according to findings published in JAMA Network Open.